David Větvička

778 total citations
30 papers, 649 citations indexed

About

David Větvička is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Větvička has authored 30 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Biomedical Engineering and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Větvička's work include Nanoplatforms for cancer theranostics (12 papers), Photodynamic Therapy Research Studies (9 papers) and Nanoparticle-Based Drug Delivery (8 papers). David Větvička is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Photodynamic Therapy Research Studies (9 papers) and Nanoparticle-Based Drug Delivery (8 papers). David Větvička collaborates with scholars based in Czechia, United States and Poland. David Větvička's co-authors include Karel Ulbrich, P Poučková, Martin Hrubý, Jiří Beneš, Jakub Rak, Blanka Řı́hová, Jan Kučka, Ondřej Hovorka, Lubomír Kovář and Hana Macková and has published in prestigious journals such as Journal of Controlled Release, Biomacromolecules and International Journal of Pharmaceutics.

In The Last Decade

David Větvička

28 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Větvička Czechia 16 232 204 173 158 148 30 649
Romina J. Glisoni Argentina 16 125 0.5× 228 1.1× 209 1.2× 222 1.4× 83 0.6× 34 809
Diego A. Chiappetta Argentina 11 236 1.0× 377 1.8× 96 0.6× 436 2.8× 119 0.8× 17 1.1k
Magali Noiray France 14 224 1.0× 282 1.4× 88 0.5× 350 2.2× 128 0.9× 30 869
Annemie Rehor Switzerland 12 274 1.2× 245 1.2× 160 0.9× 335 2.1× 118 0.8× 14 1.1k
Nate Larson United States 9 391 1.7× 523 2.6× 157 0.9× 320 2.0× 116 0.8× 10 878
Milan Paul India 17 320 1.4× 281 1.4× 72 0.4× 249 1.6× 130 0.9× 49 753
Peter P. Wibroe Denmark 12 303 1.3× 377 1.8× 138 0.8× 361 2.3× 145 1.0× 14 996
Jubo Liu Canada 10 226 1.0× 526 2.6× 260 1.5× 252 1.6× 107 0.7× 12 879

Countries citing papers authored by David Větvička

Since Specialization
Citations

This map shows the geographic impact of David Větvička's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Větvička with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Větvička more than expected).

Fields of papers citing papers by David Větvička

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Větvička. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Větvička. The network helps show where David Větvička may publish in the future.

Co-authorship network of co-authors of David Větvička

This figure shows the co-authorship network connecting the top 25 collaborators of David Větvička. A scholar is included among the top collaborators of David Větvička based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Větvička. David Větvička is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Větvička, David, Miroslav Šlouf, Magdalena Konefał, et al.. (2025). Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment. Nanomaterials. 15(22). 1690–1690.
2.
3.
Větvička, David, et al.. (2023). Proteinase-activated Receptor 2: Springboard of Tumors. Anticancer Research. 44(1). 1–12. 4 indexed citations
4.
Rak, Jakub, et al.. (2023). Advances in Liposome-Encapsulated Phthalocyanines for Photodynamic Therapy. Life. 13(2). 305–305. 20 indexed citations
5.
6.
Yu, Hang, Siyuan Tang, Weimin Tang, et al.. (2021). Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer. Journal of Controlled Release. 333. 139–150. 26 indexed citations
7.
Raus, Vladimír, Lucie Cuchalová, Rafał Poręba, et al.. (2021). SHARP hydrogel for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics. 613. 121392–121392. 15 indexed citations
8.
Větvička, David, et al.. (2021). Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release. 331. 246–259. 24 indexed citations
9.
Rak, Jakub, P Poučková, Jiří Beneš, & David Větvička. (2019). Drug Delivery Systems for Phthalocyanines for Photodynamic Therapy. Anticancer Research. 39(7). 3323–3339. 79 indexed citations
10.
Olejár, Tomáš, David Větvička, J Bouček, et al.. (2019). The FSHR Expression in Head and Neck Squamous Cell Cancer. A Pilot Immunohistochemical Study. Anticancer Research. 40(1). 349–356. 5 indexed citations
11.
Sedláček, Ondřej, Martin Studenovský, David Větvička, Karel Ulbrich, & Martin Hrubý. (2013). Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates. Bioorganic & Medicinal Chemistry. 21(18). 5669–5672. 18 indexed citations
12.
Sedláček, Ondřej, Martin Hrubý, Martin Studenovský, et al.. (2012). Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation. Bioorganic & Medicinal Chemistry. 20(13). 4056–4063. 41 indexed citations
13.
Větvička, David, et al.. (2012). Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine.. PubMed. 32(9). 3769–74. 13 indexed citations
14.
Kolbeková, Petra, David Větvička, Ján Svoboda, et al.. (2011). Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNS. Parasitology Research. 109(5). 1267–1278. 19 indexed citations
15.
Hrubý, Martin, Sergey K. Filippov, Jiří Pánek, et al.. (2010). Polyoxazoline Thermoresponsive Micelles as Radionuclide Delivery Systems. Macromolecular Bioscience. 10(8). 916–924. 82 indexed citations
16.
Kovář, Lubomír, Tomáš Etrych, Vladimír Šubr, et al.. (2010). Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells. Tumor Biology. 31(4). 233–242. 19 indexed citations
17.
Kolbeková, Petra, Libuše Kolářová, David Větvička, & Martin Syrůček. (2010). Imaging of Toxocara canis larvae labelled by CFSE in BALB/c mice. Parasitology Research. 108(4). 1007–1014. 9 indexed citations
18.
Hovorka, Ondřej, Vladimír Šubr, David Větvička, et al.. (2010). Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation. European Journal of Pharmaceutics and Biopharmaceutics. 76(3). 514–524. 45 indexed citations
19.
Pola, Robert, Martin Studenovský, Michal Pechar, et al.. (2009). HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides. Journal of drug targeting. 17(10). 763–776. 16 indexed citations
20.
Hrubý, Martin, Jan Kučka, Miroslav Vetrík, et al.. (2009). Thermoresponsive, Hydrolytically Degradable Polymer Micelles Intended for Radionuclide Delivery. Macromolecular Bioscience. 9(10). 1016–1027. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romina J. Glisoni Breakdown of academic impact, for papers by Diego A. Chiappetta Breakdown of academic impact, for papers by Magali Noiray Breakdown of academic impact, for papers by Annemie Rehor Breakdown of academic impact, for papers by Nate Larson Breakdown of academic impact, for papers by Milan Paul Breakdown of academic impact, for papers by Peter P. Wibroe Breakdown of academic impact, for papers by Jubo Liu
Rankless by CCL
2026